PLEURAL MESOTHELIOMA

Clinical trials for PLEURAL MESOTHELIOMA explained in plain language.

Never miss a new study

Get alerted when new PLEURAL MESOTHELIOMA trials appear

Sign up with your email to follow new studies for PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2 Completed 2 Terminated 1

Experimental combo for lung cancer and mesothelioma trial halted

Disease control Terminated

This study tested a new drug called SAR444245 combined with other cancer treatments for people with advanced non-small cell lung cancer or pleural mesothelioma. The goal was to see if the combination could shrink tumors. The trial was stopped early, so results are limited. About …

Matched conditions: PLEURAL MESOTHELIOMA

Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control

Last updated May 17, 2026 03:16 UTC

PLEURAL MESOTHELIOMA

Get alerted when new PLEURAL MESOTHELIOMA trials appear

Experimental combo for lung cancer and mesothelioma trial halted